SCHEMBL7835667

SCHEMBL7835667

Clc1ccc(-n2[c]nc3cccnc32)cc1

nearest known ligand 0.43

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.43
HPGD P15428 1/20 0.43
PDE4B Q07343 4/20 0.41
PDE4D Q08499 3/20 0.41
KDM4E B2RXH2 1/20 0.38
ALDH1A1 P00352 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
EP300 Q09472 1/20 0.37
CREBBP Q92793 1/20 0.37
KAT2A Q92830 1/20 0.37
KAT2B Q92831 1/20 0.37
PKM P14618 1/20 0.36
NR4A2 P43354 1/20 0.36
NOTUM Q6P988 1/20 0.36
RAB9A P51151 1/20 0.36
TP53 P04637 1/20 0.35
PDE10A Q9Y233 1/20 0.35
FLT3 P36888 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7837631 0.84 KDM4E (0.42) MAPTHPGDPDE4BPDE4DKDM4E
SCHEMBL7834859 0.83 MEN1 (0.48) MAPTHPGDPDE4BPDE4DNR4A2
SCHEMBL7833447 0.78 TBXA2R (0.44) MAPTKDM4EALDH1A1L3MBTL1EP300
SCHEMBL7835657 0.71 TSHR (0.37) ALDH1A1L3MBTL1TP53FLT3
SCHEMBL2067525 0.69 ALDH1A1 (0.35) MAPTHPGDKDM4EALDH1A1PKM
SCHEMBL7834654 0.67 HTT (0.49) MAPTHPGDKDM4EALDH1A1L3MBTL1
SCHEMBL11392810 0.66 PDE4B (0.55) MAPTHPGDPDE4BPDE4DEP300
SCHEMBL7833661 0.66 PDE10A (0.37) PDE4BPDE4DALDH1A1L3MBTL1PKM
SCHEMBL7832277 0.64 HCAR1 (0.33) MAPTHPGDKDM4EALDH1A1RAB9A
SCHEMBL11387770 0.64 PDE4B (0.56) MAPTHPGDPDE4BPDE4DKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103476767-A Heterocyclic compounds as PI3 kinase inhibitors HOFFMANN LA ROCHE 2013-12-25 CN disclosed
EP-0676398-B1 Heterocyclic compounds having anti-diabetic activity, their preparation and their use SANKYO CO (JP) 2001-10-24 EP disclosed
US-6117893-A Heterocyclic compounds having anti-diabetic activity and their use SANKYO COMPANY, LIMITED (JP) 2000-09-12 US disclosed
EP-1022274-A1 Oxazolidinedione and Thiazolidinedione derivatves, their preparation and their use Sankyo Company Limited (JP) 2000-07-26 EP disclosed
US-5977365-A HYPOGLYCEMIC AGENTS SANKYO COMPANY, LIMITED (JP) 1999-11-02 US disclosed
US-5962470-A Heterocyclic compounds having anti-diabetic activity and their use SANKYO COMPANY, LIMITED (JP) 1999-10-05 US disclosed
US-5834501-A TREATING DIABETES OR HYPERLIPEMIA SANKYO COMPANY, LIMITED (JP) 1998-11-10 US disclosed
US-5739345-A HYPOGLYCEMIC AND ANTIDIABETIC AGENTS SANKYO COMPANY, LIMITED (JP) 1998-04-14 US disclosed
US-5624935-A ANTIDIABETIC AGENTS, HYPOGLYCEMIC AGENTS OR ANTILIPEMIC AGENTS SANKYO COMPANY, LIMITED 1997-04-29 US disclosed
EP-0676398-A2 Heterocyclic compounds having anti-diabetic activity, their preparation and their use SANKYO COMPANY LIMITED (JP) 1995-10-11 EP disclosed